NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-081-2013-4-HR-01 Prefusion RSV F Proteins And Their Use HR EP 14775224.0 Issued
NIAID E-081-2013-4-CY-01 Prefusion RSV F Proteins And Their Use CY EP 14775224.0 Issued
NIAID E-081-2013-4-CZ-01 Prefusion RSV F Proteins And Their Use CZ EP 14775224.0 Issued
NIAID E-081-2013-4-BG-01 Prefusion RSV F Proteins And Their Use BG EP 14775224.0 Issued
NIAID E-081-2013-4-EP-06 Prefusion RSV F Proteins And Their Use EP National Stage 14775224.0 Issued
NIAID E-081-2013-4-GB-01 Prefusion RSV F Proteins And Their Use GB EP 14775224.0 Issued
NIAID E-081-2013-4-IN-07 Prefusion RSV F Proteins And Their Use IN National Stage 3205/KOLNP/2015 Issued
NCI E-296-2011-0-DE-01 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY DE EP 14718255.4 Issued
NCI E-296-2011-0-FR-01 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY FR EP 14718255.4 Issued
NCI E-296-2011-0-GB-01 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY GB EP 14718255.4 Issued
NCI E-296-2011-0-EP-05 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY EP National Stage 14718255.4 Issued
NIAID E-081-2013-4-BR-03 Prefusion RSV F Proteins And Their Use BR National Stage BR112015022375-3 Issued
NCI E-296-2011-0-CA-04 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY CA National Stage 2905418 Issued
NIAID E-081-2013-4-JP-15 Prefusion RSV F Proteins And Their Use JP DIV 2020-021468 Issued
NIAID E-081-2013-4-MX-10 Prefusion RSV F Proteins And Their Use MX National Stage MX/a/2015/013065 Issued
NIAID E-081-2013-4-CN-05 Prefusion RSV F Proteins And Their Use CN National Stage 201480027499.3 Issued
NIAID E-081-2013-4-JP-08 Prefusion RSV F Proteins And Their Use JP National Stage 2016-502221 Issued
NCATS E-299-2012-0-JP-03 BMP INHIBITORS AND METHODS OF USE THEREOF JP National Stage 2016-502036 Issued
NCI E-296-2011-0-AU-03 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY AU National Stage 2014244083 Issued
NIAID E-081-2013-4-AU-02 Prefusion RSV F Proteins And Their Use AU National Stage 2014243756 Issued
NCI E-289-2011-0-RU-15 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF RU National Stage 2014109741 Issued
NHGRI E-056-2013-0-DE-06 Hyposialylation Disorders DE EP 14722428.1 Abandoned
NHGRI E-056-2013-0-GB-08 Hyposialylation Disorders GB EP 14722428.1 Abandoned
NHGRI E-056-2013-0-EP-04 Hyposialylation Disorders EP National Stage 14722428.1 Abandoned
NCATS E-299-2012-0-US-05 BMP INHIBITORS AND METHODS OF USE THEREOF US National Stage 14/776,302 9682983 Issued PDF
NHGRI E-056-2013-0-US-03 Hyposialylation Disorders US ORD 14/208,570 9341619 Abandoned PDF
NCATS E-299-2012-0-PCT-02 Pyrazolo[1,5-a]pyrimidine Derivatives As Selective Inhibitors Of ALK Kinases For Inhibition Of The Bone Morphogenetic Proteins (BMP) Signaling Pathway PCT PCT PCT/US14/26042 Expired
NIAID E-081-2013-4-PCT-01 Prefusion RSV F Proteins And Their Use PCT PCT COMB PCT/US2014/026714 Expired
NCI E-296-2011-0-PCT-02 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY PCT PCT PCT/US2014/025989 Expired
NHGRI E-056-2013-0-PCT-02 Hyposialylation Disorders PCT PCT PCT/US2014/025633 Expired
NHLBI E-027-2013-0-PCT-02 Devices and Methods For Treating Functional Tricuspid Valve Reguritation PCT PCT PCT/US2014/025300 Expired
NCI E-065-2013-0-PCT-02 FKBP52 Targeting Agent Pharmaceutical Compositions PCT PCT PCT/US2014/025678 Expired
NIMH E-448-2013-0-US-02 DIAGNOSTIC METHOD FOR PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME (PANS) AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI INFECTION (PANDAS) US ORD 14/209,493 Abandoned
NHGRI E-056-2013-0-FR-07 Hyposialylation Disorders FR EP 14722428.1 Abandoned
NCATS E-299-2012-0-EP-04 BMP INHIBITORS AND METHODS OF USE THEREOF EP National Stage 14775808.0 Abandoned
NIAID E-081-2013-4-CA-04 Prefusion RSV F Proteins And Their Use CA National Stage 2902877 Pending
NCI E-111-2013-0-FR-06 TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications FR EP 14779019.0 Issued
NCI E-111-2013-0-DE-05 TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications DE EP 14779019.0 Issued
NCI E-111-2013-0-EP-03 TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications EP National Stage 14779019.0 Issued
NCI E-111-2013-0-GB-07 TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications GB EP 14779019.0 Issued
NCI E-033-2013-1-GB-08 Stabilized Single Human CD4 Domains And Fusion Proteins GB EP 14717291.0 Issued
NCI E-033-2013-1-EP-03 Stabilized Single Human CD4 Domains And Fusion Proteins EP National Stage 14717291.0 Issued
NCI E-033-2013-1-FR-07 Stabilized Single Human CD4 Domains And Fusion Proteins FR EP 14717291.0 Issued
NCI E-033-2013-1-DE-06 Stabilized Single Human CD4 Domains And Fusion Proteins DE EP 14717291.0 Issued
NIAID E-081-2013-5-US-01 PREFUSION RSV F PROTEINS AND THEIR USE US ORD 14/207,372 9738689 Issued PDF
NCI E-289-2011-0-NZ-13 YEAST-MUC1 IMMUNOTHERAPEUTIC COMPOSITIONS AND USES THEREOF NZ National Stage 622335 Issued
NIAAA E-049-2016-0-GB-09 COMPOUND FOR USE IN PROTECTING SKIN GB ORD 1404400.2 Issued
NCI E-263-2011-0-US-06 Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes US National Stage 14/241,782 9206240 Issued PDF
NINDS E-301-2007-0-US-11 Transcranial Magnetic Stimulation System And Methods US CON 14/205,388 9132278 Expired PDF
NCI E-111-2013-0-PCT-02 TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications PCT PCT PCT/US2014/24048 Expired